Hera News & Events

­

Patient derived xenograft studies from wider varieties of patient sub-populations promise improved clinical trial selection and design

Around 85% of preclinical drugs entering clinical trials in oncology [...]

By |August 9th, 2018|

OncoRat® PDX models highlighted in Drug Discovery News (DDN) Special Report on Cancer: Aiming for Avatars

While advances in in-vitro platforms have allowed researchers to better [...]

By |July 18th, 2018|

Hera Biolabs to present at the 2018 AACR Annual Meeting.

Hera Biolabs will be presenting xenograft, PDX, and humanization of [...]

By |April 12th, 2018|

Understanding Transporter-Mediated Drug-Drug Interactions Using Humanized Liver Mice

Pharmaceutical researchers and regulators are increasingly aware of the influence [...]

By |January 31st, 2018|

Using Patient Derived Xenografts to Improve Therapeutic Cancer Treatments

An increased understanding of human tumors has created a solid [...]

By |January 30th, 2018|

Humanized immune-system SRG Rats™ & mice for immuno-oncology

The SRG rat demonstrates robust immune-system humanization with peripheral blood [...]

By |January 29th, 2018|

Humanized Mouse Models Advance Immunotherapeutic Strategies in Treatment of Type 1 Diabetes

A relatively common autoimmune disease, Type 1 Diabetes (T1D) is [...]

By |October 17th, 2017|

Humanized Mouse Models Advance Immunotherapeutic Strategies in Treatment of Type 1 Diabetes

A relatively common autoimmune disease, Type 1 Diabetes (T1D) is [...]

By |October 17th, 2017|

Using Cell Sheet Technique to Study the Development of HCC in Rat Models

As the single most prevalent primary liver cancer and the [...]

By |October 17th, 2017|

Understanding Circadian Rhythms in Humanized Mice

The human body’s circadian rhythm can significantly impact many biological [...]

By |October 17th, 2017|